Saint Petersburg Institute of Bioregulation and Gerontology

The Saint Petersburg Institute of Bioregulation and Gerontology is a leading research organization specializing in gerontology and the development of peptide-based medicinal products. Established in 1992, the institute is best known for the discovery and application of Khavinson Peptides, which are short-chain peptides that act as epigenetic regulators to restore protein synthesis in specific organs. Its product portfolio includes several clinically approved drugs in Russia and the CIS, such as Retinalamin for ophthalmology and Cortexin for neurology, as well as an extensive line of dietary supplements. The institute conducts comprehensive research into the mechanisms of aging, focusing on telomerase activation and the slowing of age-related physiological decline. Through its commercial partners, the institute's bioregulation technologies are distributed globally for use in anti-aging medicine and rehabilitation.